NCT02208830

Brief Summary

The hypothesis of this study is that the group of patients who will carry out the rehabilitation program associated with respiratory therapy will have higher benefits in physical function, peripheral muscle strength and quality of life compared to the group that will only perform chest physiotherapy. Additionally, there will be a negative correlation between inflammatory mediators and measures of physical ability as well as the magnitude of improvement is lower after treatment in patients with higher baseline levels of inflammation. Furthermore, these patients will be reevaluated in 1 and 3 years, as a cohort, studying if exercise capacity may be a predictor of clinical and functional outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2012

Completed
2.4 years until next milestone

First Posted

Study publicly available on registry

August 5, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

September 1, 2022

Status Verified

August 1, 2022

Enrollment Period

6 years

First QC Date

March 7, 2012

Last Update Submit

August 27, 2022

Conditions

Keywords

bronchiectasisfunctional capacitylung functional

Outcome Measures

Primary Outcomes (4)

  • The change in exercise capacity in patients with bronchiectasis

    Exercise capacity is measured by maximal cardiopulmonary exercise test on a cycle ergometer. The protocol will be used in ramp.

    Up to 36 months

  • Pulmonary Function

    For the cohort follow up, forced expiratory volume in the first second will be primary outcome

    Up to 36 months

  • Exacerbations and Hospitalizations per year

    For the cohort follow up, the frequency of exacerbations and hospitalizations will be evaluated

    Up to 36 months

  • Survival in months

    For the cohort follow up, the survival will be evaluated in months.

    Up to 36 months

Other Outcomes (1)

  • Peripheral muscle function is measured by

    Up to 36 months

Study Arms (2)

conventional program

EXPERIMENTAL

The conventional program is conducted with duration of 8 week, twice weekly. The techniques used will be: expiration with the glottis open in lateral posture (Eltgol), autogenous drainage (AD) and shaker. Each technique will last for 30 minutes.

Other: conventional program

pulmonary rehabilitation

EXPERIMENTAL

Duration of 8 week, twice weekly exercise program with: lower limb strength training and aerobic training per 30 minutes.

Other: pulmonary rehabilitation

Interventions

Pulmonary rehabilitation: 8 week, twice weekly exercise program with aerobic treadmill training and lower limb strength training.

Also known as: exercise, rehabilitation, treatment, pulmonary
pulmonary rehabilitation

The conventional program is conducted with duration of 8 week, twice weekly. The techniques used will be: expiration with the glottis open in lateral posture (Eltgol), autogenous drainage (AD) and shaker. Each technique will last for 30 minutes.

Also known as: physiotherapy, treatment respiratory
conventional program

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with clinical and / or CT of bronchiectasis without cystic fibrosis
  • Clinically stable (no change in symptoms of dyspnea, quantity and color of the secretion)
  • Greater than 18 and / or oxygen dependent at home
  • Medical Research Council MRC ≥ 1.

You may not qualify if:

  • Smokers or smoking history\> 10 pack / years,
  • Cystic fibrosis (CF)
  • Chronic obstructive pulmonary disease (COPD)
  • Asthma
  • Pulmonary fibrosis (PF)
  • Musculoskeletal limitations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Nove de Julho

São Paulo, 01504001, Brazil

Location

Related Publications (1)

  • de Camargo AA, de Castro RAS, Vieira RP, Oliveira-Junior MC, Araujo AA, De Angelis K, Rached SZ, Athanazio RA, Stelmach R, Corso SD. Systemic Inflammation and Oxidative Stress in Adults with Bronchiectasis: Association with Clinical and Functional Features. Clinics (Sao Paulo). 2021 Apr 16;76:e2474. doi: 10.6061/clinics/2021/e2474. eCollection 2021.

MeSH Terms

Conditions

Bronchiectasis

Interventions

ExerciseRehabilitationTherapeuticsPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaAftercareContinuity of Patient CarePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Anderson Alves de Camargo, master's

    University of Nove de Julho

    PRINCIPAL INVESTIGATOR
  • Rejane Agnelo Silva de Castro, Student

    University of Nove de Julho

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 7, 2012

First Posted

August 5, 2014

Study Start

January 1, 2012

Primary Completion

January 1, 2018

Study Completion

July 1, 2018

Last Updated

September 1, 2022

Record last verified: 2022-08

Locations